“This is the 16th vaccine to enter trials globally but is the first covid-19 vaccine developed in the southern hemisphere to enter human trials, and the first covid-19 vaccine designed with the help of A.I,” said Professor Nikolai Petrovsky.

Sypharma has a long-standing relationship with Vaxine with over a decade of manufacturing Advax delta inulin adjuvant, and are excited and are honoured to partner with this ground-breaking work in bringing a covid-19 vaccine to market.

Sypharma undertook the fill and finish of the Covid-19 vaccine and the manufacture of the Advax delta inulin adjuvant products.